Pear Bio ^Companies

Pear Bio s a computational biology company developing a 3D immune-microtumor technology that recreates core parts of the human tumor-immune microenvironment for functional precision medicine testing and drug discovery. The Pear platform combines 3D cell culture, functional testing, computer vision and multi-omics analysis. Pear Bio has active clinical trials to predict patient response to therapy, and an internal drug discovery pipeline based on the functional and multi-omic analysis of patient tumor and blood samples and real-world patient data.